ADVERTISEMENT
Search

Posted: Jan 7, 2020

The status of DIR fees: Your questions answered

DIR Fees

It’s been a stop-and-go journey toward the elimination of the retroactive direct and indirect remuneration (DIR) fees that are causing intense turmoil in the pharmacy community, particularly in the independent pharmacy space.

Rachel Balick

Read more
Posted: Jan 7, 2020

Prescriber alleges defamation after pharmacy refuses to fill prescriptions

On The Docket

A controlled substance prescription must be issued for a legitimate medical purpose and in the usual course of professional practice.

David B. Brushwood, BSPharm, JD

Read more
Posted: Jan 7, 2020

Pharmacist-led population health strategies improve statin use

Statins

Pharmacist interventions can increase the percentage of patients with atherosclerotic cardiovascular disease (ASCVD) who are on appro-priate statin therapy and improve an organization’s quality metrics when conducted as part of a novel population health initiative, show new data by Haby and colleagues published in a recent issue of the Journal of the American Pharmacists Association.

Maria G. Tanzi, PharmD

Read more
Posted: Jan 7, 2020

OTC birth control would expand patient access

Contraception

In late September, the American College of Obstetricians and Gyne-cologists (ACOG) published an update to its position on OTC hor-monal contraceptives.

Loren Bonner

Read more
Posted: Jan 7, 2020

Is a nonprofit approach the future of antibiotic development?

Antibiotics

Last August, FDA approved pretomanid, a new antibiotic used in com-bination with bedaquiline (Sirturo—Janssen) and linezolid for treat-ment of patients with multidrug-resistant and extensively drug-resistant tuberculosis (TB).

Aina Abell

Read more
First6263646566676870

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT